Heterogeneity-based Genome Search Meta-analysis for Preeclampsia
Authors
Affiliations
Preeclampsia is a pregnancy-related disorder that causes maternal and fetal morbidity and mortality. Its exact inheritance pattern is still unknown, and genome searches for identifying susceptibility loci for preeclampsia have thus far produced inconclusive or inconsistent results. We performed a heterogeneity-based genome search meta-analysis (HEGESMA) that synthesized the available genome scan data on preeclampsia. HEGESMA identifies genetic regions (bins) that rank highly on average in terms of linkage statistics across genome scans (searches). The significance of each bin's average rank and heterogeneity across scans was calculated using Monte Carlo tests. The meta-analysis involved four genome-scans on general preeclampsia and five scans on severe preeclampsia. In general preeclampsia, 13 bins had significantly high average rank (Prank< 0.05) by either unweighted or weighted analyses, while four of them (2p11.2-2q21.1, 9q21.32-9q31.2, 2p15-2p11.2, 2q32.1-2q35) were formally significant by both analyses. Heterogeneity of bin 2.8 (2q32.1-2q35) was significantly low in both unweighted and weighted analysis (PQ< 0.01). In severe preeclampsia, 10 bins had significantly high average rank by either unweighted or weighted analyses and five of them (3q11.1-3q21.2, 2q37.1-2q37.3, 18p11.32-18p11.22, 2p15-2p11.2, 7q34-7q36.3) were significant by both analyses. Bin 2q37.1-2q37.3 showed marginal low heterogeneity in unweighted and weighted analysis (PQ= 0.06). Results should be interpreted with caution as the p values were modest. Further investigation of these regions by genotyping with additional markers and families may help to direct the identification of candidate genes for preeclampsia.
Replication of chromosomal loci involved in Parkinson's disease: A quantitative synthesis of GWAS.
Rikos D, Siokas V, Burykina T, Drakoulis N, Dardiotis E, Zintzaras E Toxicol Rep. 2021; 8:1762-1768.
PMID: 34712594 PMC: 8528647. DOI: 10.1016/j.toxrep.2021.10.008.
Poon L, Shennan A, Hyett J, Kapur A, Hadar E, Divakar H Int J Gynaecol Obstet. 2019; 145 Suppl 1:1-33.
PMID: 31111484 PMC: 6944283. DOI: 10.1002/ijgo.12802.
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions.
Williams P, Morgan L Pharmgenomics Pers Med. 2012; 5:37-51.
PMID: 23226061 PMC: 3513227. DOI: 10.2147/PGPM.S23141.
Insights into the genetic architecture of diabetic nephropathy.
Palmer N, Freedman B Curr Diab Rep. 2012; 12(4):423-31.
PMID: 22573336 PMC: 3389140. DOI: 10.1007/s11892-012-0279-2.
Zdoukopoulos N, Doxani C, Messinis I, Stefanidis I, Zintzaras E BMC Pregnancy Childbirth. 2011; 11:89.
PMID: 22051068 PMC: 3217889. DOI: 10.1186/1471-2393-11-89.